| Literature DB >> 31911517 |
Xiaofei Huang1, Yongbo Hu2,3, Longqi Du4, Xiaolong Lin5, Wenli Wu6, Lijun Fan7, Libo Li8, Xiaowei Zhong1, Qiyong Gong2, Li Gao9, Weihong Kuang10.
Abstract
OBJECTIVE: The metabolic syndrome is a major risk factor for cardiovascular disease. Little information exists on the prevalence of the metabolic syndrome at high-altitude areas in China. We aimed to estimate the prevalence of metabolic syndrome and its individual components at high altitude.Entities:
Keywords: China; high altitude; hypertension; metabolic syndrome; obesity
Mesh:
Year: 2020 PMID: 31911517 PMCID: PMC6955486 DOI: 10.1136/bmjopen-2019-032840
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Characteristics of the participants by gender and region
| Total (n=5053) | Men (n=2221) | Women (n=2832) | Township (n=769) | Countryside (n=4284) | |
| Age (years) | 41.8 (13.6) | 42.0 (13.9) | 41.7 (13.4) | 38.1 (12.3)† | 42.5 (13.7) |
| Height (cm) | 165.3 (8.1) | 171.1 (6.5)*** | 160.8 (6.1) | 166.1 (8.2)** | 165.2 (8.0) |
| BMI (kg/m2) | 23.6 (3.7) | 24.3 (3.8)*** | 23.1 (3.5) | 24.2 (4.0)† | 23.5 (3.6) |
| SBP (mm Hg) | 127.3 (23.7) | 129.7 (23.6)*** | 125.4 (23.6) | 121.9 (19.9)† | 128.3 (24.2) |
| DBP (mm Hg) | 81.5 (14.2) | 83.2 (14.4)*** | 80.2 (13.9) | 80.7 (13.3) | 81.7 (14.4) |
| FBG (mmol/L) | 5.1 (1.3) | 5.2 (1.4)*** | 5.1 (1.1) | 5.2 (1.4)* | 5.1 (1.2) |
| TG (mmol/L) | 1.2 (0.9) | 1.3 (1.2)*** | 1.1 (0.5) | 1.5 (1.7)† | 1.1 (0.6) |
| HDL (mmol/L) | 1.29 (0.12) | 1.27 (0.11)*** | 1.30 (0.13) | 1.26 (0.15)† | 1.29 (0.11) |
Data are mean (SD).
*p<0.05 for township versus countryside. **p<0.01 for township versus countryside. ***p<0.001 for men versus women.†p<0.001 for township versus countryside.
BMI, body mass index; DBP, diastolic blood pressure; FBG, fasting serum glucose; HDL, high-density lipoprotein; SBP, systolic blood pressure; TG, triglyceride.
Prevalence of metabolic syndrome and individual components of metabolic syndrome by gender and region
| MetS | BMI≥25.0 | Dyslipidaemia | Hypertension or medication use | Hyperglycaemia or medication use | |
| Total | 3.6 | 31.6 | 9.1 | 29.7 | 4.8 |
| Men | 5.9** | 38.2** | 15.4** | 33.8** | 6.7** |
| Women | 1.8 | 26.4 | 4.2 | 26.2 | 3.2 |
| Township | 6.6*** | 39.4*** | 22.4*** | 24.2*** | 6.5* |
| Men (n=377) | 11.9** | 49.1** | 36.1** | 30.2** | 10.9** |
| Women (n=392) | 1.5 | 30.1 | 9.2 | 18.4 | 2.3 |
| Countryside | 3.0 | 30.2 | 6.7 | 30.7 | 4.5 |
| Men (n=1844) | 4.6** | 36.0** | 11.2** | 34.5** | 5.9** |
| Women (n=2440) | 1.8 | 25.8 | 3.4 | 27.8 | 3.4 |
Data are percentage.
*p<0.05 for township versus countryside. **p<0.001 for men versus women. ***p<0.001 for township versus countryside.
BMI, body mass index; MetS, metabolic syndrome.
Prevalence of one or more components of metabolic syndrome by gender and region
| Number of metabolic abnormalities | 1 | 2 | 3 | 4 |
| Total | 33.9 | 14.3 | 3.0 | 0.6 |
| Men | 35.3 | 19.4** | 4.9** | 1.0** |
| Women | 32.7 | 10.3 | 1.5 | 0.3 |
| Township | 28.0*** | 20.4*** | 4.8† | 1.8*** |
| Men | 31.6* | 26.5** | 8.2** | 3.4** |
| Women | 24.5 | 14.5 | 1.5 | 0.3 |
| Countryside | 34.9 | 13.2 | 2.6 | 0.4 |
| Men | 36.1 | 18.0** | 4.2** | 0.5 |
| Women | 34.1 | 9.6 | 1.5 | 0.3 |
Data are percentage. Metabolic abnormalities: body mass index ≥25.0 kg/m2, dyslipidaemia, hypertension or medication use, and hyperglycaemia or medication use.
*p<0.05 for men versus women. **p<0.01 for men versus women. ***p<0.001 for township versus countryside. †p<0.01 for township versus countryside.
Age-specific prevalence of individual components of metabolic syndrome
| Age (years) | Gender | BMI≥25.0 | Dyslipidaemia | Hypertension or medication use | Hyperglycaemia or medication use |
| 18–29 | Total (n=1000) | 20.9 | 6.4 | 6.4 | 0.7 |
| Men (n=455) | 28.4*** | 9.7*** | 10.1*** | 0.7 | |
| Women (n=545) | 14.7 | 3.7 | 3.3 | 0.7 | |
| 30–39 | Total (n=1302) | 31.3 | 9.0 | 15.4 | 2.6 |
| Men (n=541) | 43.8*** | 18.3*** | 19.4** | 4.1** | |
| Women (n=761) | 22.5 | 2.4 | 12.6 | 1.6 | |
| 40–49 | Total (n=1449) | 40.8 | 10.6 | 30.0 | 5.7 |
| Men (n=638) | 47.6*** | 18.5*** | 34.5** | 8.5*** | |
| Women (n=811) | 35.4 | 4.3 | 26.5 | 3.6 | |
| 50–59 | Total (n=684) | 34.6 | 11.1 | 53.9 | 7.9 |
| Men (n=305) | 34.8 | 17.0* | 57.4 | 10.5* | |
| Women (n=379) | 34.6 | 6.3 | 51.2 | 5.8 | |
| 60–69 | Total (n=450) | 24.7 | 8.9 | 68.0 | 11.3 |
| Men (n=202) | 26.2 | 11.9* | 71.8 | 16.8** | |
| Women (n=248) | 23.4 | 6.5 | 64.9 | 6.9 | |
| ≥70 | Total (n=168) | 24.4 | 6.5 | 75.6 | 7.1 |
| Men (n=80) | 25.0 | 7.5 | 75.0 | 5.0 | |
| Women (n=88) | 23.9 | 5.7 | 76.1 | 9.1 |
Data are percentage.
*p<0.05 for men versus women. **p<0.01 for men versus women. ***p<0.001 for men versus women.
BMI, body mass index.
Figure 1Age distributions of participants and age-specific prevalence of metabolic syndrome by gender. MetS, metabolic syndrome. *p<0.05 for men versus women.
Multiple logistic regression analysis of risk factors of metabolic syndrome and its components
| MetS | BMI≥25.0 | Dyslipidaemia | Hypertension or medication use | Hyperglycaemia or medication use | |
| Gender | |||||
| Female | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) |
| Male | 3.42 (2.46–4.75)*** | 1.72 (1.53–1.94)*** | 3.75 (3.02–4.66)*** | 1.42 (1.25–1.60)*** | 2.14 (1.64–2.80)*** |
| Residential region | |||||
| Countryside | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) |
| Township | 2.25 (1.61–3.14)*** | 1.50 (1.28–1.76)*** | 3.98 (3.24–4.90)*** | 0.72 (0.60–0.86)*** | 1.49 (1.08–2.06)* |
| Age | |||||
| Young age | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) |
| Middle age | 3.29 (2.35–4.60)*** | 1.41 (1.24–1.61)*** | 1.36 (1.10–1.68)** | 4.39 (3.80–5.08)*** | 2.95 (2.18–4.00)*** |
| Old age | 3.01 (2.02–4.70)*** | 0.76 (0.62–0.92)** | 0.98 (0.72–1.34) | 13.16 (10.79–16.05)*** | 4.32 (3.06–6.09)*** |
| Living altitude | |||||
| 2000–2499 m | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) |
| 2500–2999 m | 0.95 (0.67–1.34) | 1.05 (0.91–1.21) | 0.58 (0.47–0.71)*** | 1.55 (1.36–1.81)*** | 0.94 (0.69–1.29) |
| ≥3000 m | 0.73 (0.49–1.10) | 0.80 (0.68–0.94)** | 0.42 (0.32–0.54)*** | 1.63 (1.38–1.93)*** | 1.06 (0.76–1.50) |
Data are OR (95% CIs). Young age: 18–44 years. Middle age: 45–59 years. Old age:≥60 years. Multiple ogistic regressions were used to assess the association between gender, residential region, age and living altitude and metabolic syndrome (MetS) and its components.
*p<0.05, **p<0.01, ***p<0.001.
BMI, body mass index.